Mexican Social Security Institute: Regional General Hospital No. 1
Mérida, Yucatán, 97000, Mexico
NCT Number: NCT06809738
Type of study: Case series. Universe of study: Records of patients with Fournier syndrome treated using the 3-stage reconstructive technique assigned and treated at the Mexican Social Security Institute: Regional General Hospital No. 1 of Mérida, Yucatán, during the years 2021-2024.
Population under study: Patients diagnosed with Fournier syndrome.
Looking for future studies?
Notify Me40 year–85 year
Male
Interventional
Phase 3
Mérida, Yucatán, 97000, Mexico
The first surgical stage consists of damage limitation and extension analysis. In the second surgical stage, it was necessary to wash and prepare the area to be remodeled with the joint creation of the testicular resting space delimited by the fascia of the adductor muscles of the proximal lower limb. Finally, in the third surgical stage, the wound is remodeled and addressed. The surgery was performed in patients with extensive involvement that could not be resolved with minor surgery.
The 3-stage reconstructive technique can be summarized as follows:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: From the diagnosis to the surgery and 30 day post op
To determine the presence of mortality in patients with Fournier syndrome who underwent surgery using the 3-stage reconstructive technique.
Instituto Mexicano del Seguro Social
Other Gov
Proposal for an Anatomical Scale for the Prognosis of Fournier Syndrome.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07552779
COVID-19, COVID-19 (Coronavirus Disease 2019)
Brussels, Bruxelles-capitale, Région de, Belgium
View Trial DetailsNCT01264055
Bronchial Diseases, Bronchiectasis
Stanford, California, United States
View Trial DetailsNCT07673484
Allergic Contact Dermatitis, Cicatrix
Küçükçekmece, Istanbul, Turkey (Türkiye)
View Trial DetailsNCT02505386
Infections
Bordeaux, France
View Trial Details